Pharmabiz12h
FABA inks MoU with Thu Dau Mot University to set up FABA chapter in Vietnam
FABA inks MoU with Thu Dau Mot University to set up FABA chapter in Vietnam: Our Bureau, Bengaluru Wednesday, September 25, ...
Pharmabiz17h
Health ministry notifies Rules to register CROs under NDCTR, 2019
Health ministry notifies Rules to register CROs under NDCTR, 2019: Gireesh Babu, New Delhi Wednesday, September 25, 2024, ...
Pharmabiz7h
Theriva achieves target patient enrollment in VIRAGE phase 2b trial of VCN-01 with gemcitabine/nab-paclitaxel to treat metastatic pancreatic cancer
Rockville, Maryland Wednesday, September 25, 2024, 18:00 Hrs [IST] ...
Pharmabiz7h
LEO Pharma’s Anzupgo cream receives European marketing approval for adults with moderate to severe chronic hand eczema
LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult ...
Pharmabiz12h
Roche introduces cobas Respiratory flex test to use its TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses
Roche introduces cobas Respiratory flex test to use its TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses: Basel Wednesday, September 25, 2024, ...
Pharmabiz8h
Experts highlight urgent need for novel anti-infectives at the 7th Annual National Conference by Society of Neurocritical Care of India
Our Bureau, Mumbai Wednesday, September 25, 2024, 17:50 Hrs [IST] ...
Pharmabiz8h
Chugai receives Japanese additional indication approval for Evrysdi in pre-symptomatic SMA and additional dosage for infants under 2 months of age
Chugai receives Japanese additional indication approval for Evrysdi in pre-symptomatic SMA and additional dosage for infants under 2 months of age: Tokyo Wednesday, September 25, ...
Pharmabiz10h
Aileron Therapeutics completes patient enrollment in Cohort 2 of phase 1b trial of LTI-03 in idiopathic pulmonary fibrosis
Aileron Therapeutics completes patient enrollment in Cohort 2 of phase 1b trial of LTI-03 in idiopathic pulmonary fibrosis: Austin, Texas Wednesday, September 25, 2024, 15:00 Hrs ...
Pharmabiz9h
NIH awards $27 million to establish new network of genomics-enabled learning health systems
NIH awards $27 million to establish new network of genomics-enabled learning health systems: Bethesda, Maryland Wednesday, September 25, 2024, 16:00 Hrs [IST] The National Institu ...
Pharmabiz11h
Joint WHO Europe-FIP high-level dialogue raises awareness of pharmaceutical services among policymakers
Joint WHO Europe-FIP high-level dialogue raises awareness of pharmaceutical services among policymakers: Our Bureau, Bengaluru Wednesday, September 25, 2024, 14:15 Hrs [IST] World ...
Pharmabiz9h
Takeda receives Japanese nod to manufacture and market Fruzaqla to treat unresectable advanced or recurrent colorectal cancer
Takeda receives Japanese nod to manufacture and market Fruzaqla to treat unresectable advanced or recurrent colorectal cancer: Osaka, Japan Wednesday, September 25, 2024, 16:30 Hr ...
Pharmabiz12h
WHO & MDBs kick off US$ 1.5 bn primary health financing platform with new funds and launch of first investment plans in 15 countries
WHO & MDBs kick off US$ 1.5 bn primary health financing platform with new funds and launch of first investment plans in 15 countries: New York, USA Wednesday, September 25, 2024, ...